RxDoctor Payments DataLook up a doctor →

Marc Uemura, MD

Internal Medicine · Eugene, ORNPI 1487971081

Payments from drug & device makers

$1,553,770in general payments, 2019–2025

Across 355 payments — averaging $4376.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$972K
  • Biontech SE$170K
  • Eli Lilly$119K
  • Novartis$73K
  • Ipsen Bioscience Inc.$64K
  • Novocure Inc.$50K
  • plus $106K from 10 others

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,553,770 in reported general payments places this provider in the 95th percentile of 1,363 internal medicine providers in Oregon.

See all internal medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$2,374,388
Medicare patients
443
Services billed
88,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Eugene

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →